MC-Val-Cit-PAB-rifabutin-5 mg

Description
MC-Val-Cit-PAB-rifabutin is a agent-linker conjugate for ADC with potent antitumor activity by using rifabutin (an DNA-dependent RNA polymerase inhibitor), linked via the ADC linker MC-Val-Cit-PAB.-4°C (Powder, sealed storage, away from moisture)-Applications-Cancer-programmed cell death-Formula-C74H101ClN10O17-Citation–References-[1]Staben LR, et al. Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem. 2016 Dec;8(12):1112-1119.-CASNumber-2055900-34-8-MolecularWeight-1438.10-Compound Purity-95.33-SMILES-O=C1C2=C(C(C)=C(C3=C2C4=NC5(NC4=C(C3=O)N6)CC[N+](CC(C)C)(CC5)CC7=CC=C(C=C7)NC([C@@H](NC([C@@H](NC(CCCCCN8C(C=CC8=O)=O)=O)C(C)C)=O)CCCNC(N)=O)=O)O)O[C@]1(C)O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@H]([C@H](/C=C/C=C(C)C6=O)C)O.[Cl-]-Research_Area-Cancer-Solubility-DMSO : 20 mg/mL (ultrasonic)-Target-Drug-Linker Conjugates for ADC-Isoform-Traditional Cytotoxic Agents-Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related